These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18800146)

  • 41. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
    Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
    Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cancer stem cell concepts--lesson from leukemia].
    Nitta E; Suda T
    Nihon Rinsho; 2009 Oct; 67(10):1863-7. PubMed ID: 19860180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease.
    Shi Y; Su Z; Li S; Chen Y; Chen X; Xiao Y; Sun M; Ping Q; Zong L
    Mol Pharm; 2013 Jun; 10(6):2479-89. PubMed ID: 23646913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ara-C and anti-CD47 antibody combination therapy eliminates acute monocytic leukemia THP-1 cells in vivo and in vitro.
    Wang Y; Yin C; Feng L; Wang C; Sheng G
    Genet Mol Res; 2015 May; 14(2):5630-41. PubMed ID: 26125761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells.
    Leyton JV; Williams B; Gao C; Keating A; Minden M; Reilly RM
    Leuk Res; 2014 Nov; 38(11):1367-73. PubMed ID: 25278187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
    She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K
    Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eradication of leukemia stem cells as a new goal of therapy in leukemia.
    Ravandi F; Estrov Z
    Clin Cancer Res; 2006 Jan; 12(2):340-4. PubMed ID: 16428470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
    Wang Z; Chen CC; Chen W
    Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
    Kikushige Y; Akashi K
    Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel combination treatments targeting chronic myeloid leukemia stem cells.
    Al Baghdadi T; Abonour R; Boswell HS
    Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):94-105. PubMed ID: 22178144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective elimination of leukemia stem cells: hitting a moving target.
    Crews LA; Jamieson CH
    Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
    Hope KJ; Jin L; Dick JE
    Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
    Gao L; Yu S; Zhang X
    Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting myeloid leukemia stem cells.
    Jordan CT
    Sci Transl Med; 2010 May; 2(31):31ps21. PubMed ID: 20463365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vivo Generation of Leukemic Stem Cells by HSC Targeting by Transgenesis.
    Vicente-Dueñas C
    Methods Mol Biol; 2021; 2185():361-372. PubMed ID: 33165860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias.
    Zhai X; Jiang X
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular pathogenesis of leukemia and leukemic stem cells (LSCs).
    Kizaki M
    Int J Hematol; 2019 Jan; 109(1):3-4. PubMed ID: 30353275
    [No Abstract]   [Full Text] [Related]  

  • 60. Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics.
    Mastelaro de Rezende M; Ferreira AT; Paredes-Gamero EJ
    J Cell Physiol; 2020 Jun; 235(6):4989-4998. PubMed ID: 31709540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.